Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

Interpharm Holdings, Inc. (IPAH)

0.0041
0.0000
(0.00%)
At close: April 29 at 4:00:00 PM EDT
Loading Chart for IPAH
  • Previous Close 0.0000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0001 - 0.0001
  • 52 Week Range 0.0001 - 0.0100
  • Volume 10,000
  • Avg. Volume 0
  • Market Cap (intraday) 2.069M
  • Beta (5Y Monthly) -56.92
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0900
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Interpharm Holdings, Inc. develops, manufactures, and markets generic prescription strength and over-the-counter pharmaceuticals. The company supplies its medicines to major retailers, wholesalers, managed care organizations, and national distributors. The company was founded in 1984 and is based in Hauppauge, New York.

670

Full Time Employees

June 30

Fiscal Year Ends

Recent News: IPAH

View More

Performance Overview: IPAH

Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IPAH
0.00%
S&P 500 (^GSPC)
5.45%

1-Year Return

IPAH
59.00%
S&P 500 (^GSPC)
8.69%

3-Year Return

IPAH
4,000.00%
S&P 500 (^GSPC)
34.58%

5-Year Return

IPAH
485.71%
S&P 500 (^GSPC)
89.18%

Compare To: IPAH

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IPAH

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -42.42%

  • Return on Assets (ttm)

    -18.53%

  • Return on Equity (ttm)

    -117.07%

  • Revenue (ttm)

    69.21M

  • Net Income Avi to Common (ttm)

    -33.69M

  • Diluted EPS (ttm)

    -0.0900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    41k

  • Total Debt/Equity (mrq)

    343.06%

  • Levered Free Cash Flow (ttm)

    -21.74M

Research Analysis: IPAH

View More

Company Insights: IPAH

Research Reports: IPAH

View More

People Also Watch